Join the Breast Cancer - Palliative group to help and get support from people like you.
Breast Cancer - Palliative News (Page 3)
Chemo Causes Lasting Physical Decline In Breast Cancer Survivors
TUESDAY, March 4, 2025 – Breast cancer survivors treated with chemotherapy tend to suffer a longer-lasting decline in their physical health, compared to women who receive hormone therapy or other...
Uptake of Supportive Care Low for Patients With Advanced Cancer
FRIDAY, Feb. 28, 2025 – Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive care, according to a study published online Feb....
Stressors Affect Systemic Inflammation, Tumor Aggressiveness in Breast Cancer
THURSDAY, Feb. 27, 2025 – For women with breast cancer, stressors are associated with deleterious alterations to the systemic and tumor immune environment, according to a study published online Feb....
Breast Cancer Incidence Rates Vary by Region in U.S. Women Younger Than 40
THURSDAY, Feb. 27, 2025 – For U.S. women younger than 40 years, breast cancer incidence rates vary by geography, according to a study published online Feb. 12 in Cancer Causes & Control. Rebecca D....
Young Women's Locale Plays Role In Breast Cancer Risk
WEDNESDAY, Feb. 26, 2025 – Where a young American woman lives could play a role in her risk for breast cancer, a new study suggests. In fact, the breast cancer risk associated with a young woman’s l...
Minority Groups Less Likely to Receive Diagnostic Services After Abnormal Mammogram
WEDNESDAY, Feb. 19, 2025 – For patients after screening mammography, onsite availability of most diagnostic services is similar across race and ethnicity groups, but minority groups are less likely...
Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers
FRIDAY, Feb. 7, 2025 – Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involved patients with...
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 – For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding...
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 – The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor ...
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (HR)-positive, ...
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 – For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall survival more than...
AI-Supported Double Mammogram Reading Improves Detection Rate
TUESDAY, Jan. 14, 2025 – Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with...
Nonadherence to Cancer Screening Varies by Screening Type
THURSDAY, Jan. 9, 2025 – Nonadherence to cancer screening varies by screening type and sex, according to a study published online Jan. 3 in JAMA Network Open. Ami E. Sedani, Ph.D., M.P.H., from the...
Individuals With Advanced Breast Cancer at Diagnosis More Likely to Have CVD
MONDAY, Jan. 6, 2025 – Individuals with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease (CVD), according to a study published online Jan. 2 in JAMA...
The Heart Disease, Breast Cancer Link
MONDAY, Jan. 6, 2025 – Heart disease and cancer might seem completely unrelated, but these two top causes of death sometimes act in concert. Women with heart disease appear to have a greater risk of...
Further information
Related condition support groups
Related drug support groups
fluorouracil, testosterone, estradiol, Premarin, Estrace, tamoxifen